New York (NY) Asbestos Resources & Information:
From 1979 to 1999, most of the asbestos-related deaths in the Empire State were in the working-class borough of Queens, with 228 being from mesothelioma and 62 from asbestosis. In contrast, in the nearby borough of Bronx, there were only 69 and 24 respectively. Part of this is due to population; the population of Queens is about 1/3 larger than that of its neighboring borough. Queens is also more industrialized, and it is industrial occupations that run the highest risk of asbestos exposure.
In New York State as a whole, there are nearly 400 jobsites, public buildings and institutions at which asbestos exposure has been an issue. Although the high-risk industries--shipyards, power generation plants, oil refineries and chemical companies--are certainly well represented, the list includes nearly everything else: schools, public housing units, sewage treatment plants, office facilities, churches and synagogues, and even restaurants and food preparation companies.
Before going into some of the details of these, however, it is worth looking at the Empire State's naturally-occurring asbestos as well as a mining operation at which workers have been suffering unusually high rates of asbestos-related disease and non-industrial accidents resulting in asbestos exposure.
The Talc Mines
In 2007, there was an asbestos scare in Connecticut schools over clay that contained talc contaminated with asbestos fibers being used in art classes. While administrators attempted to assuage fears by stating that asbestos amounts in said clay were negligible, it should be noted that until 1981, Jefferson County, one of two areas in northeastern New York state in which talc is mined, had one of the highest rates of mesothelioma in the nation.
This corresponds with the Agency for Toxic Substances and Disease Registry asbestos map, which places one of New York state's naturally-occurring asbestos deposits within Jefferson County in the vicinity of Governeur. The other two, which were the sites of mining operations, are located further east near the Vermont state line.
Accidental and Other Non-Industrial Exposure
The asbestos fallout resulting from the collapse of the World Trade Center has been covered extensively elsewhere. Suffice it to say here that over 5,000 tons of the W.R. Grace & Company product Monokote was used on the iron framework, and possibly more. Asbestos fibers rained down on Lower Manhattan and Brooklyn in the days that followed, and there continue to be elevated respiratory problems to this day.
Another problem that is ongoing is that of aging underground steam pipes, insulated with asbestos, that finally explode. This happened in Manhattan during the summer of 2007 as well as in Boston the following September; it has in fact happened a number of times in major cities over the past twenty years as corporate tax loopholes cause government revenues to dry up, with aging infrastructure not being maintained properly often the result.
Why So Many Non-Industrial Buildings?
New York City was arguably the birthplace of the modern American asbestos industry. Although the substance had been used for centuries, it was Henry Ward Johns, founder of what later became Johns-Manville, who started developing and marketing asbestos building materials in Manhattan just prior to the U.S. Civil War.
As a result, a huge number of old and historic buildings in the Mid-Atlantic and New England States have required extensive asbestos abatement. A 1988 EPA estimate suggested that at the time, there were perhaps as many as 500,000 public buildings nationwide in which asbestos may have been a problem.
Although asbestos abatement has become a major industry and such projects are undertaken on a regular basis, progress is slow; asbestos continues to be discovered in these buildings on a regular basis.
Asbestos Danger: New York (NY) Job Sites
Over the course of the last century, hundreds of thousands of workers were exposed to asbestos while on the job – and for the most part, they were not warned. Below is a list of Job sites covered on Asbestos.net from the state of New York (NY) where workers were potentially and unnecessarily put at risk:
New York (NY) Asbestos & Mesothelioma Doctors
The diagnosis and treatment of asbestos-related cancers and other diseases is gradually becoming a sub-specialty in the field of medicine all its own. However, as of the present time, there is no medical degree that is specific to asbestos-related practice.
Most doctors focusing on asbestos disease today are trained in oncology, thoracic surgery, respiratory or occupational medicine, or some related field. Below is a list of doctors in New York (NY) that specialize in some form of asbestos cancer or mesothelioma treatment and the institution they are currently affiliated with:
Dr. David H. Ilson (Click on name for more info...)
Associate Attending Physician at Memorial Sloan-Kettering Cancer Center
New York, New York (NY)
Dr. Harvey I. Pass (Click on name for more info...)
Director of the Division of Thoracic Surgery at New York University Medical Center
New York, New York (NY)
Dr. Lee M. Krug (Click on name for more info...)
Assistant Attending Physician at Memorial Sloan-Kettering Cancer Center - Division of Thoracic Oncology
New York, New York (NY)
Dr. Manjit S. Bains (Click on name for more info...)
Thoracic Surgeon at Memorial Sloan-Kettering Cancer Center (MSKCC)
New York, New York (NY)
Dr. Philippe A. Chahinian (Click on name for more info...)
Oncologist at The Derald H. Ruttenberg Treatment Center
New York, New York (NY)
Dr. Raja Michael Flores (Click on name for more info...)
Attending Thoracic Surgeon at Memorial Sloan-Kettering Cancer Center, Department of Thoracic Surgery
New York, New York (NY)
Dr. Robert N. Taub (Click on name for more info...)
Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons
New York, New York (NY)
Dr. Roman Perez-Soler (Click on name for more info...)
Associate Director of Clinical Oncology at New York University Medical Center
New York, New York (NY)
Dr. Scott J. Swanson (Click on name for more info...)
Surgeon at Mount Sinai Medical Center, Thoracic Surgery and Cardiothoracic Surgery
New York, New York (NY)
Dr. Stephen M. Levin (Click on name for more info...)
Associate Professor at The Mount Sinai School of Medicine, Community and Preventive Medicine
New York, New York (NY)
Dr. Valerie W. Rusch (Click on name for more info...)
Chief, Thoracic Service at Memorial-Sloan Kettering Cancer Center, William G. Cahan Chair
New York, New York (NY)
New York (NY) Asbestos & Mesothelioma Treatment Centers
Today, between 25 and 30% of all Americans will get some form of cancer during their lifetimes. There are many reasons for this, including the modern lifestyle and the poisons that have been put into the environment – of which asbestos is a prime example.
The number of clinics and hospitals that specialize in oncology have increased in response to the growing number of patients. Below is a list of the cancer treatment centers located in New York (NY) that we feature on Asbestos.net:
Hematology and Oncology Associates of Central New York
East Syracuse, New York (NY)
Herbert Irving Comprehensive Cancer Center
New York, New York (NY)
Memorial Sloan-Kettering Cancer Center
New York, New York (NY)
New York University Medical Center - NYU Langone Medical Center
New York, New York (NY)
New York-Presbyterian Hospital , Columbia University Medical Center
New York, New York (NY)
Roswell Park Cancer Institute
Buffalo, New York (NY)
Clinical Trials Serving New York (NY):
A clinical trial is when new medications and treatments are tested on human subjects. Participation in such studies can entail some risks, but for some who are facing an invariably fatal disease, they also represent an opportunity – not only for personal relief, but to serve the greater good in the advancement of medical knowledge.
Below is a list of clinical trials with locations in New York (NY):
Identifier: NCT00025207 (Click for more info...)
Title: A Phase II Study Of ZD 1839 (NSC 715055, IND 61187) In Patients With Malignant Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00054002 (Click for more info...)
Title: Surgery and Intracavitary Photodynamic Therapy (PDT) for the Treatment of Malignant Pleural Mesothelioma; The Use of Light Delivery Fibers With Large Diffusers
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00509041 (Click for more info...)
Title: A Phase II Study of Dasatinib (NSC #732517) in Patients With Previously Treated Malignant Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Recruiting
Identifier: NCT00005636 (Click for more info...)
Title: A Single-Blind Randomized Phase III Trial of MTA Plus Cisplatin Versus Cisplatin in Patients With Malignant Pleural Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Net Yet Recruiting
Identifier: NCT00107432 (Click for more info...)
Title: A Phase II Study of BAY 43-9006 (NSC #724772, IND #69896) in Patients With Malignant Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00004183 (Click for more info...)
Title: Capecitabine (Xeloda) in Malignant Mesothelioma: A Phase II Study
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00039182 (Click for more info...)
Title: A Phase II Study of Oral EGFR Tyrosine Kinase Inhibitor OSI-774 (NSC-718781) in Patients With Malignant Pleural Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00003723 (Click for more info...)
Title: Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00027508 (Click for more info...)
Title: Phase II Study Of ET-743 In Patients With Unresectable Malignant Pleural Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00072397 (Click for more info...)
Title: A Multicenter Phase II Trial of Neo-Adjuvant Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00003974 (Click for more info...)
Title: An Evaluation of the Immunological Parameters Associated With a Skin-Test and Immunization of Lung and Mesothelioma Cancer Patients With Autologous Lung Tumor Associated Antigen: Characterization of the Patients' Cytolytic and Helper T Cell Reactivity for Identification of the Specific Antigen(s): A Pilot Study
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00061477 (Click for more info...)
Title: ALIMTA Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma: A Phase II Clinical Trial
Information Profided By: Eli Lilly and Company
Trial Status: Completed
Identifier: NCT00004033 (Click for more info...)
Title: Phase II Clinical Study of a Liposome Entrapped Cisplatin Analog (L-NDDP) Administered Intrapleurally in Patients With Malignant Pleural Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00027703 (Click for more info...)
Title: A Double Blind, Placebo Controlled Randomized Phase II Trial Of Gemcitabine And Cisplatin With Or Without The VEGF Inhibitor Bevacizumab (NSC #704865) In Patients With Malignant Mesotheloma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00398138 (Click for more info...)
Title: Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Thoracic and Myeloid Neoplasms
Information Profided By: National Cancer Institute (NCI)
Trial Status: Recruiting
Identifier: NCT00024271 (Click for more info...)
Title: Phase II Trial Of Combined Resection, Intraperitoneal Chemotherapy, And Whole Abdominal Radiation For Treatment Of Peritoneal Mesothelioma
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00629343 (Click for more info...)
Title: A Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide In Patients With Unresectable Or Metastatic Soft Tissue Sarcoma or Malignant Mesothelioma
Information Profided By: Columbia University
Trial Status: Recruiting
Identifier: NCT00062283 (Click for more info...)
Title: A Phase II, Open-Label, Non-Randomized, Multicenter, Single Agent Study of Intravenous SDX-102 for the Treatment of Patients With MTAP-Deficient Cancer
Information Profided By: National Cancer Institute (NCI)
Trial Status: Active, Not Recruiting
Identifier: NCT00087698 (Click for more info...)
Title: A Multicenter Phase II Trial of Neo-Adjuvant Pemetrexed (Alimta) Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
Information Profided By: Eli Lilly and Company
Trial Status: Active, Not Recruiting
Identifier: NCT00413075 (Click for more info...)
Title: Open Label, Dose Escalation Trial of Oral PXD101 in Patients With Advanced Solid Tumors
Information Profided By: CuraGen Corporation
Trial Status: Recruiting
Identifier: NCT00055705 (Click for more info...)
Title: A Phase I Clinical Trial To Assess The Safety And Efficacy Of Intraperitoneal PV701 Administrations In Patients With Advanced Or Recurrent Malignancy Largely Confined To The Peritoneal Cavity
Information Profided By: National Cancer Institute (NCI)
Trial Status: Completed
Identifier: NCT00132704 (Click for more info...)
Title: An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Information Profided By: Memorial Sloan-Kettering Cancer Center
Trial Status: Recruiting
New York (NY) Legal Resources: Asbestos, Asbestos Cancer & Mesothelioma
A search through the New York Federal District Court Cases for asbestos-related personal injury product liability lawsuits brings up an extensive list of more than forty cases from 2006 and 2007. Some of these cases are issues such as petitions for removal from asbestos litigation or federal questions regarding asbestos being answered by the New York Court. However, many of these cases are personal injury lawsuits brought by individuals affected by asbestos-related disease.
New York is ranked fourth in the U.S. for mesothelioma cases. With a mesothelioma mortality rate of 10.79 per million, New York has a crude mortality rank of 32 in the country.
In 2003, a key New York asbestos case was settled. A New York jury awarded more than $47 million to a boilermaker who worked as a contractor for Consolidated Edison Inc. and the KeySpan Corp. unit of Long Island Lighting Co. The man was diagnosed with mesothelioma in May, 2001. The jury found the two New York utility companies negligent both in their actions and in their failure to advise workers of asbestos's dangers.
In the 2005 case Seitz v. Jacobson & Company, an appeals court in New York overturned a ruling by a Workers' Compensation Board Panel. The panel had determined that an asbestos claimant did not file a timely appeal, but the appeals court found instead that the Panel had overlooked an extension the plaintiff was granted in which to file the appeal. The court reversed the Panel's dismissal of the claims, and sent the case back to the Panel to determine whether the right to death benefits ceased with the death of the victim's surviving spouse. The case stemmed from John Seitz, a sheet metal worker who claimed to have developed metastatic small cell anaplastic lung cancer after being exposed to asbestos in his workplace. After Seitz died, his widow filed a workers' compensation claim. Seitz's wife also passed away before the case was decided, and the judge closed the case. The case was reopened on behalf of the estate of the sheet metal worker. The case opened the question of whether a claim could still be made even after the widow had passed away.
Those interested in filing lawsuits should know that the statute of limitations for personal injury law in New York is three years, with a discovery rule for toxic exposure that states that this amount of time begins when the problem (in this case the mesothelioma) either was discovered or should have been discovered. Wrongful death cases in the state have a two-year statute of limitations, with the time beginning at the date of death. While New York has no specific statute concerning asbestos product personal injury suits, according to the state's Workers' Compensation Law 3, compensation is payable for injuries or death incurred by employees who are involved in the manufacture of asbestos.